by In2Pharma | Jan 14, 2021 | News
Belgium To meet the requirements of the Sunshine Act, disclosure of premiums and benefits granted to Belgian healthcare professionals, healthcare organizations and patient organizations must be uploaded on betransparent.be every year by the end of May. From now on, a...
by In2Pharma | Jul 1, 2020 | News
Belgium On June 30, the transfers of value from the pharmaceutical and medical device industry to the healthcare industry have been disclosed on betransparent.be. This is already the third disclosure of collaborations under the legal framework of the Sunshine Act. A...
by In2Pharma | Oct 19, 2018 | News
Belgium The main reason for the update of the Mdeon Code of Ethics is to align it with the Sunshine Act. Simultaneously, the Practical Guidelines of the code have been adapted as well. The two major changes are: Adaptation of the chapter on the transparency obligation...
by In2Pharma | Aug 31, 2017 | News
On 22 August 2017, the Royal Decree of 31 July 2017 was published in the Belgian Official Journal. This Royal Decree confirms the recognition of the non-profit-making association Mdeon to perform the transparency tasks that were entrusted to the FAMHP. Mdeon is now...
by In2Pharma | Apr 14, 2017 | News
FAMHP On December 27th 2016, the Sunshine Act was adopted in Belgium. It introduces a new transparency obligation applicable to the pharmaceutical and medical devices industries. The legislation requires pharmaceutical manufacturers, importers and distributors, as...